← 返回前沿论文

NK 细胞动态演变与 CRS + HIPEC 介导的免疫重塑:恶性腹膜间皮瘤的预后机制及治疗意义

英文原题:Dynamic evolution of NK cells and immune remodeling mediated by CRS + HIPEC: prognostic mechanisms and therapeutic implications for malignant peritoneal mesothelioma.

查看英文原题

Dynamic evolution of NK cells and immune remodeling mediated by CRS + HIPEC: prognostic mechanisms and therapeutic implications for malignant peritoneal mesothelioma.

PubMed 2025/11/03(内容时间) World J Surg Oncol Q1 · IF 2.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

术前 NK 细胞耗竭与血栓形成及手术风险相关,而术后 NK 细胞恢复受 KPS、特定细胞因子(IL-4/5/6/8)影响,并在 CRS + HIPEC 后显著增强。

研究思路结论见上方概要

恶性腹膜间皮瘤(MPM)是一种高度侵袭性的腹膜恶性肿瘤,在肿瘤细胞减灭术(CRS)联合腹腔热灌注化疗(HIPEC)后复发率显著。迫切需要探索MPM的新型治疗策略。自然杀伤(NK)细胞在抗肿瘤免疫中表现出快速反应性;然而,NK细胞在MPM中的动态演化及临床意义仍不清楚。

本研究回顾性纳入80例新诊断MPM患者(术前组)和64例接受CRS+HIPEC的患者(术后组)。采用流式细胞术定量检测外周血中NK细胞(CD3-CD56dimCD16+)水平。进行单因素和多因素回归分析,以评估NK细胞计数与临床病理特征、术中事件及预后之间的关联。建立NK细胞恢复的多因素预测模型。

41例患者(51.3%)术前表现出NK细胞水平降低,这与血栓形成风险增加(P = 0.023)、术中血浆输注(P = 0.004)和住院时间延长(P = 0.023)显著相关。术后NK细胞水平的动态变化与Karnofsky功能状态评分(KPS)(P = 0.048)以及IL-4、IL-5、IL-6和IL-8水平升高(P < 0.05)相关。多因素分析显示,术中血浆输注量是术前NK细胞减少的独立相关因素(P = 0.013),而低KPS评分是术后NK细胞下降的独立预测因素(P = 0.048)。生存分析表明,高围手术期应激评分(PSS)(P = 0.015)、淋巴结转移(P = 0.015)、术中显著出血量(P = 0.013)、术前CD8⁺ T细胞水平低(P = 0.001)以及术后IL-17表达降低(P = 0.013)是总生存期(OS)的独立不良预后因素。此外,动态NK细胞恢复模型显示,基线NK细胞水平、腹膜癌指数(PCI)、CD8⁺ T细胞状态和术后恢复时间均显著影响免疫重塑过程(均P < 0.001)。

展开英文摘要原文

Malignant peritoneal mesothelioma (MPM) is a highly aggressive peritoneal malignancy with a significant recurrence rate following cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC). There is an urgent need to investigate novel therapeutic strategies for MPM. Natural killer (NK) cells exhibit rapid responsiveness in anti-tumor immunity; however, NK cells' dynamic evolution and clinical significance in MPM remain unclear.

This study retrospectively enrolled 80 newly diagnosed MPM patients (preoperative group) and 64 patients who underwent CRS + HIPEC (postoperative group). The level of NK cells (CD3 - CD56 dim CD16 + ) in peripheral blood was quantified using flow cytometry. Univariate and multivariate regression analyses were performed to evaluate the association between NK cell counts and clinicopathological characteristics, intraoperative events, and prognosis. A multivariate prediction model for NK cell recovery was established.

41 patients (51.3%) exhibited decreased NK cell levels preoperatively, which were significantly associated with an increased risk of thrombosis (P = 0.023), intraoperative plasma transfusion (P = 0.004), and prolonged hospitalization duration (P = 0.023). Postoperative dynamic changes in NK cell levels were found to correlate with Karnofsky performance scale (KPS) scores (P = 0.048) and elevated levels of IL-4, IL-5, IL-6, and IL-8 (P < 0.05). Multivariate analysis revealed that the volume of intraoperative plasma transfusion was an independent correlated factor for preoperative NK cell reduction (P = 0.013), while a low KPS score was an independent predictor of postoperative NK cell decline (P = 0.048). Survival analysis indicated that a high perioperative stress score (PSS) (P = 0.015), lymph node metastasis (P = 0.015), significant intraoperative blood loss (P = 0.013), low preoperative CD8⁺ T cell levels (P = 0.001), and reduced postoperative IL-17 expression (P = 0.013) were independent adverse prognostic factors for overall survival (OS). Furthermore, the dynamic NK cell recovery model demonstrated that baseline NK cell levels, peritoneal cancer index (PCI), CD8⁺ T cell status, and postoperative recovery time all significantly influenced the immune remodeling process (all P < 0.001).

Preoperative NK depletion correlated with thrombosis and surgical risks, while postoperative NK recovery was influenced by KPS, specific cytokines (IL-4/5/6/8), and was significantly enhanced after CRS + HIPEC.

论文信息

作者
Liu YT、Zhao QD、Liang XL、Ma R、Su YD、Yang R、Wei T、Wu HL
第一作者单位
Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.China
通讯作者单位
Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China. liyansd2@163.com.China
期刊
World journal of surgical oncology2025 Nov 3
原文标识
PubMed 41184923 · DOI 10.1186/s12957-025-04019-2